Telomir Pharmaceuticals (TELO) Shares Outstanding (2022 - 2026)
Telomir Pharmaceuticals (TELO) posted Shares Outstanding (Entity) of $34.4 million for Q4 2025, up 1.63% sequentially from $33.8 million in Q3 2025, and up 15.52% YoY from $29.8 million in Q4 2024.
Telomir Pharmaceuticals (TELO) Shares Outstanding (2022 - 2026) Analysis & Trends
Telomir Pharmaceuticals has reported Shares Outstanding (Entity) for 4 years, with the latest figure at $34.4 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 15.52% year-over-year to $34.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $34.4 million (up 15.52% YoY) and the FY2025 annual result came in at $34.4 million, up 15.52% from the prior year.
- Shares Outstanding (Entity) advanced to $34.4 million in Q4 2025 per TELO's latest filing, from $33.8 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $34.4 million in Q4 2025 and troughed at $26.8 million in Q4 2022.
- A 4-year average of $29.5 million and a median of $29.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The widest YoY moves for Shares Outstanding (Entity): up 15.52% in 2025, down 0.52% in 2025.
- Over 4 years, Shares Outstanding (Entity) stood at $26.8 million in 2022, then grew by 6.64% to $28.6 million in 2023, then gained by 4.03% to $29.8 million in 2024, then advanced by 15.52% to $34.4 million in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $34.4 million, $33.8 million, and $30.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 133.61 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 217.35 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 445.06 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 241.70 Mn |
| 10 | Telomir Pharmaceuticals | 68.14 Mn | 68.14 Mn | - | 60.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60.84 Mn |
| Dec 31, 2025 | 31.65 Mn |
| Sep 30, 2025 | 32.40 Mn |
| Jun 30, 2025 | 30.01 Mn |
| Mar 31, 2025 | 29.76 Mn |
| Dec 31, 2024 | 29.54 Mn |
| Sep 30, 2024 | 29.61 Mn |
| Jun 30, 2024 | 29.61 Mn |
| Mar 31, 2024 | 27.77 Mn |
| Dec 31, 2023 | 27.30 Mn |
| Sep 30, 2023 | 27.10 Mn |
| Jun 30, 2023 | 27.10 Mn |
| Mar 31, 2023 | 26.89 Mn |
| Dec 31, 2022 | 26.83 Mn |